Pediatric acute myeloid leukemia with t (8; 16)(p11; p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Münster …
EA Coenen, CM Zwaan, D Reinhardt… - Blood, The Journal …, 2013 - ashpublications.org
In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
Pediatric acute myeloid leukemia with t (8; 16)(p11; p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster …
EA Coenen, CM Zwaan, D Reinhardt, CJ Harrison… - Blood, 2013 - pure.au.dk
In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
Pediatric acute myeloid leukemia with t (8; 16)(p11; p13), a distinct clinical and biological entity: a collaborative study by the International Berlin-Frankfurt-Munster AML …
EA Coenen, CM Zwaan, D Reinhardt, CJ Harrison… - BLOOD, 2013 - biblio.ugent.be
In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
[HTML][HTML] Pediatric acute myeloid leukemia with t (8; 16)(p11; p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt …
EA Coenen, CM Zwaan, D Reinhardt, CJ Harrison… - Blood, 2013 - Elsevier
In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
Pediatric acute myeloid leukemia with t (8; 16)(p11; p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster …
EA Coenen, CM Zwaan, D Reinhardt, CJ Harrison… - Blood, 2013 - eprints.ncl.ac.uk
In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
[HTML][HTML] Pediatric acute myeloid leukemia with t (8; 16)(p11; p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt …
EA Coenen, CM Zwaan, D Reinhardt, CJ Harrison… - Blood, 2013 - ncbi.nlm.nih.gov
In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
Pediatric acute myeloid leukemia with t (8; 16)(p11; p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster …
EA Coenen, CM Zwaan, D Reinhardt, CJ Harrison… - BLOOD, 2013 - cris.unibo.it
In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
[PDF][PDF] Pediatric acute myeloid leukemia with t (8; 16)(p11; p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt …
EA Coenen, CM Zwaan, D Reinhardt, CJ Harrison… - Blood, 2013 - academia.edu
In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
Pediatric acute myeloid leukemia with t (8; 16)(p11; p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Münster …
EA Coenen, CM Zwaan, D Reinhardt, CJ Harrison… - Blood, 2013 - cir.nii.ac.jp
抄録< jats: title> Key Points</jats: title>< jats: p> Pediatric t (8; 16)(p11; p13) AML is a rare
entity defined by a unique gene expression signature and distinct clinical features …
entity defined by a unique gene expression signature and distinct clinical features …
[PDF][PDF] Pediatric acute myeloid leukemia with t (8; 16)(p11; p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt …
EA Coenen, CM Zwaan, D Reinhardt, CJ Harrison… - Blood, 2013 - researchgate.net
In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …